PBC
GILD icon

Pavion Blue Capital’s Gilead Sciences GILD Stock Holding History

Pavion Blue Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Hold
2,345
– – 0.12% 84
2026
Q1 		$327K Hold
2,345
– – 0.14% 77
2025
Q4 		$288K Hold
2,345
– – 0.12% 83
2025
Q3 		$260K Hold
2,345
– – 0.11% 89
2025
Q2 		$260K Hold
2,345
– – 0.12% 86
2025
Q1 		$263K Hold
2,345
– – 0.13% 85
2024
Q4 		$217K Buy
+2,345
New +$211K 0.1% 96
2023
Q2 		– Sell
-2,440
Closed -$202K – 100
2023
Q1 		$202K Hold
2,440
– – 0.12% 96
2022
Q4 		$209K Buy
+2,440
New +$193K 0.13% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pavion Blue Capital's GILD Position: Q2 2026 in Review

Pavion Blue Capital held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,345 shares worth $296K. The position accounts for 0.12% of the portfolio, ranked #84.

Pavion Blue Capital first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $327K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pavion Blue Capital held 2,345 shares of Gilead Sciences worth $296K as of Q2 2026.
  • Pavion Blue Capital left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.12% of Pavion Blue Capital's portfolio in Q2 2026, its #84 holding.
  • Pavion Blue Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
  • Pavion Blue Capital's Gilead Sciences position peaked at $327K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pavion Blue Capital's 13F filing for Q2 2026, filed 7 Aug 2026.